Effect Profile
Describes the acute effect. This profile does not influence the OpenMind Score.
No effect profiles yet. Describe the acute effect without changing the long-term score.
Please log in to add effect details
Log inDescription
Rapé (also spelled hapé or rapeh; pronounced ha-PEH) is a traditional shamanic snuff preparation originating from the western Amazon basin, where it has been used for centuries — possibly millennia — by indigenous peoples of present-day Brazil, Peru and Bolivia. The preparation consists of finely ground Nicotiana rustica (mapacho) tobacco blended with plant ash (tsunu, murici, paricá, samauma and many others), sometimes incorporating additional botanical ingredients such as tree barks, seeds, or aromatic herbs. The resulting powder is extremely fine — far more so than commercial snuff — and is administered directly into the nostrils using specialised blowpipes.
Among the best-documented user communities are the Yawanawá, Kaxinawá (Huni Kuin), Nukini, Katukina and Matsés peoples. In these cultures rapé is not regarded as a recreational substance but as a ceremonial and medicinal tool. It is used in rituals of purification, prayer, hunting preparation, healing ceremonies and spiritual practice. The knowledge of specific blend recipes is typically passed down within communities and often closely guarded.
Composition
The two essential components of every rapé blend are:
- Nicotiana rustica (mapacho) — a tobacco species native to the Americas that is far more potent than the commercially cultivated Nicotiana tabacum. Mapacho contains up to 9% nicotine by dry weight (compared to 1–3% in N. tabacum) along with higher concentrations of β-carbolines (harman and norharman), which exhibit mild monoamine oxidase inhibitory (MAOI) activity.
- Plant ash (cinza) — alkaline ash obtained by burning the bark or wood of specific trees. The ash serves multiple functions: it alkalinises the mixture (raising pH), which converts nicotine to its freebase form for enhanced mucosal absorption; it contributes mineral content and characteristic flavour; and it defines the "type" of the blend.
Popular ash sources include:
- Tsunu — from the Platycyamus regnellii tree; one of the most widely available blends, considered grounding and centering
- Paricá — from Schizolobium amazonicum; traditionally associated with cleansing
- Murici — from Byrsonima species; aromatic, considered uplifting
- Samauma — from the Ceiba pentandra (kapok tree); associated with strength and protection
- Imburana — from Commiphora leptophloeos; sweet, aromatic profile
- Cocoa (Theobroma cacao) ash — adds a gentle, warm character
Additional ingredients found in specific blends include tonka bean (Dipteryx odorata), cinnamon bark, clove, mint, camphor, and in some cases seeds from Anadenanthera peregrina (yopo) — the latter adding tryptamine alkaloids (bufotenin, DMT) to the preparation.
Pharmacology
The primary pharmacological agent in rapé is nicotine, delivered at high concentration via rapid nasal absorption.
Nicotine pharmacology:
- Acts as an agonist at nicotinic acetylcholine receptors (nAChRs), particularly α4β2 and α7 subtypes
- Triggers release of dopamine (reward, attention), noradrenaline (alertness, vasoconstriction), serotonin (mood), acetylcholine (cognitive function) and β-endorphin (pain modulation)
- Nasal bioavailability is high (estimated 50–80%) due to the rich vascular supply of the nasal mucosa and the alkaline pH of the ash, which keeps nicotine in its unionised, absorbable freebase form
- Onset via nasal absorption is rapid (30–120 seconds to peak plasma levels), comparable to smoked tobacco
β-Carbolines (harman, norharman):
- Present in Nicotiana rustica at higher concentrations than in N. tabacum
- Exhibit reversible MAO-A and MAO-B inhibitory activity
- This MAOI action may synergistically enhance nicotine's effects by slowing the metabolism of released monoamines (dopamine, serotonin, noradrenaline)
- Contribute to the subjective differences between mapacho-based preparations and conventional tobacco
Alkaline ash (pH modulation):
- Raises the pH of the preparation to approximately 8–10
- At alkaline pH, nicotine exists predominantly in its freebase (unionised) form, which crosses biological membranes far more readily than the protonated (salt) form
- This is the same pharmacological principle exploited in modern nicotine pouch and snus products
Effects
Rapé produces a distinctive and intense experience that differs markedly from smoking or chewing tobacco:
Immediate effects (first 1–5 minutes):
- Intense burning or stinging sensation in the nasal passages, often described as overwhelming for first-time users
- Profuse watery eyes and nasal discharge
- Sharp, sudden head rush followed by a wave of alertness
- Brief period of disorientation or "emptying of the mind" — experienced practitioners describe this as mental clearing or reset
- Possible nausea (especially in nicotine-naive individuals)
Short-term effects (5–45 minutes):
- Mental clarity and sharpened focus
- Calm alertness without agitation
- Grounding sensation — feeling more present and centered
- Mild mood elevation
- Temporary decongestion of the sinuses (followed by rebound congestion in some users)
- Slight appetite suppression
At higher doses or in sensitive individuals:
- Dizziness, lightheadedness
- Nausea and possible vomiting
- Cold sweats, pallor
- Tachycardia and increased blood pressure
- Tremor
- In extreme cases of nicotine toxicity: seizures, loss of consciousness
The subjective experience of rapé is consistently described by users as qualitatively different from smoking tobacco — more grounding, centering, and "clear-headed" rather than the stimulating buzz of cigarettes. This likely reflects the combined action of nicotine, β-carbolines and the specific alkaloid profile of Nicotiana rustica.
Application
Rapé is administered using two traditional blowpipe instruments:
Kuripe (self-administration)
A V-shaped or curved pipe, typically 10–15 cm long, made from bamboo, bone or hardwood. One end is placed in the mouth, the other in the nostril. The user blows sharply with a single, forceful puff to propel the powder deep into the nasal cavity. Self-administration with a kuripe requires practice — the blow must be firm and confident.
Tepi (partner administration)
A longer pipe (30–60 cm), used by a second person to blow rapé into the recipient's nostrils. In traditional contexts, the administrator is typically a healer, shaman or experienced practitioner. Tepi application allows for more controlled dosing and is considered the traditional, ceremonial method.
Application technique:
- Load a small amount of rapé into the pipe's powder chamber (start with a pea-sized amount per nostril)
- Take a deep breath and hold it briefly
- Apply one sharp, complete blow into the first nostril
- Wait 30–60 seconds, then repeat in the second nostril
- Remain seated, breathe through the mouth, and allow mucus to drain naturally
- Spit rather than swallow the dripping mucus
Harm Reduction
- Nicotine toxicity is the primary acute risk. Nicotiana rustica delivers far more nicotine than cigarette tobacco. Symptoms of overdose include severe nausea, vomiting, pallor, diaphoresis, tachycardia, tremor and in severe cases convulsions. Nicotine-naive users should start with the absolute minimum amount.
- Nasal health: regular use irritates the nasal mucosa and can lead to chronic rhinitis, nosebleeds, and erosion of nasal tissue. Rinse with isotonic saline after each session. Space sessions out to allow mucosal recovery.
- MAOI interaction: the β-carboline content of Nicotiana rustica provides mild endogenous MAOI activity. Adding exogenous MAOIs (ayahuasca, Syrian rue, pharmaceutical MAOIs) amplifies both the nicotine and monoamine effects dangerously.
- Dependence: rapé is habit-forming due to its nicotine content. Regular users develop tolerance and dependence. Withdrawal manifests as irritability, anxiety, craving and difficulty concentrating. Limiting use to occasional, intentional sessions reduces dependence risk.
- Respiratory considerations: unlike smoked tobacco, rapé does not involve combustion or inhalation into the lungs. Nevertheless, aspiration of fine powder into the airways is a risk if application technique is poor — always blow into the nose, never inhale during application.
- Purity and sourcing: obtain rapé from reputable sources that work directly with indigenous producers. Low-quality products may contain excessive moisture (promoting mould growth), adulterants, or may use Nicotiana tabacum instead of Nicotiana rustica — resulting in an inauthentic product with different pharmacological properties.
Cultural Context
Rapé occupies a central role in the spiritual pharmacopoeia of numerous Amazonian peoples. It is typically applied before ayahuasca ceremonies to "clear" the participant; used during hunting preparation to sharpen focus and senses; blown into the nostrils of the ill as part of healing rituals; and shared communally as a social and spiritual bond.
The growing global interest in rapé has created a market that provides income for indigenous communities but also raises questions about cultural appropriation, sustainability, and quality control. Understanding and respecting the cultural origins of rapé is an important aspect of its responsible use.
Related Compounds
- Nicotine — the primary active alkaloid; a potent nAChR agonist responsible for most pharmacological effects
- Nicotiana rustica (mapacho) — the whole tobacco plant, also smoked as cigars or used in teas in Amazonian traditions
- Nicotiana tabacum — the commercially cultivated tobacco species, lower in nicotine and β-carbolines
- Yopo (Anadenanthera peregrina) — a separate Amazonian snuff containing bufotenin and DMT; sometimes confused with rapé but pharmacologically distinct
- Bufotenin (5-HO-DMT) — tryptamine alkaloid found in yopo seeds, occasionally added to certain rapé blends
- Kanna (Sceletium tortuosum) — another traditional snuffed preparation, but acting primarily via serotonin reuptake inhibition rather than nicotinic receptors
Dosage
Insufflated
| Threshold | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| 50-100 mg | 100-250 mg | 250-500 mg | 500-1000 mg | 1000-2000 mg |
Duration
Insufflated
Safer Use
- All dosages are approximate and refer to the total powder (tobacco + ash + additives) administered to both nostrils combined. Potency varies enormously between blends — some contain more Nicotiana rustica, others rely more heavily on plant ash. Always start with the smallest amount your kuripe can hold.
- Rapé delivers a very high dose of nicotine extremely rapidly via the nasal mucosa. Nicotine-naive individuals are at risk of acute nicotine poisoning — symptoms include severe nausea, vomiting, dizziness, cold sweats, tachycardia and in extreme cases seizures. Start very low.
- Never combine rapé with other nicotine products (cigarettes, snus, vapes, nicotine patches) simultaneously. Stacking nicotine from multiple sources greatly increases the risk of nicotine overdose.
- Avoid combining rapé with MAOIs (including ayahuasca or Syrian rue). Some traditional ceremonies use both, but MAO inhibition dramatically amplifies nicotine toxicity by blocking its primary metabolic pathway.
- Use proper application tools — a kuripe for self-administration or a tepi administered by an experienced person. Improvised devices risk uncontrolled dosing or choking on the fine powder.
- After application, allow mucus to drain naturally and spit rather than swallow. Swallowing large amounts of nicotine-rich mucus can cause nausea and gastrointestinal discomfort.
- Stay hydrated. Rapé can cause temporary sinus pressure, watery eyes, and nasal irritation. Rinsing the nose with saline solution after the session helps protect the nasal mucosa.
- Do not use rapé if you have pre-existing cardiovascular conditions (hypertension, arrhythmia, coronary disease). Nicotine acutely raises heart rate and blood pressure.
- Nicotiana rustica is significantly more potent than common cigarette tobacco (Nicotiana tabacum). It contains up to 9% nicotine by dry weight compared to 1–3% in N. tabacum. Treat it with corresponding respect.
- Rapé is habit-forming. Regular use leads to nicotine dependence with withdrawal symptoms (irritability, anxiety, craving, difficulty concentrating) upon cessation. Limit frequency of use.
Detection Times
| Method | Detection Window |
|---|---|
| Urine | 3–4 days |
| Blood | 1–3 days |
| Saliva | 1–4 days |
| Hair | 1–90 days |
Note: Rapé delivers nicotine, which is metabolised to cotinine — the primary biomarker used in nicotine testing. Standard cotinine immunoassays (cutoff typically 200 ng/mL) will detect rapé use. Quantitative LC-MS/MS testing for cotinine and trans-3-hydroxycotinine is used in clinical and insurance screening. Detection windows depend on frequency and amount of use; chronic users may test positive for longer.
Legal Status
This information is provided for educational purposes only and does NOT constitute legal advice. Laws change frequently and may vary by region, state, or municipality. Always verify the current legal status in your jurisdiction before making any decisions. Open Mind assumes no liability for the accuracy, completeness, or timeliness of this data.
Country Details Show 13 countries
DE Germany Legal
Rapé is legal in Germany. It is a tobacco product based on Nicotiana rustica and not a controlled substance.
Nicotiana rustica and plant-ash-based snuff preparations are not listed in the BtMG or NpSG. As a tobacco-containing product, rapé falls under tobacco product regulations, though traditional/ceremonial snuff preparations are generally not subject to the same marketing requirements as conventional cigarettes. The EU Tobacco Products Directive (2014/40/EU) applies to smokeless tobacco products including nasal snuff.
AT Austria Legal
Rapé is legal in Austria. Not a controlled substance.
As a tobacco-containing product, rapé is regulated under tobacco legislation rather than drug laws. Not listed in the SMG or NPSG.
CH Switzerland Legal
Rapé is legal in Switzerland. Not a controlled substance.
Switzerland has a tradition of nasal snuff use. Rapé as a tobacco product is regulated under the Tabakproduktegesetz (TabPG). Not listed in BetmVV-EDI controlled substance schedules.
NL Netherlands Legal
Rapé is legal in the Netherlands and widely sold in smartshops and ethnobotanical shops.
Not listed under the Opiumwet. As a tobacco product, it is subject to Dutch tobacco regulations (Tabaks- en rookwarenwet). The EU ban on oral tobacco (snus) does not apply to nasal tobacco/snuff products.
GB United Kingdom Legal
Rapé is legal in the UK. Tobacco products are exempt from the Psychoactive Substances Act 2016.
Tobacco and nicotine products are explicitly exempted from the PSA 2016 (Schedule 1, paragraph 4). Rapé, as a tobacco-containing product, falls under this exemption. Subject to the Tobacco and Related Products Regulations 2016 (implementing EU TPD).
FR France Legal
Rapé is legal in France. Not a controlled substance.
Tobacco products including nasal snuff are legal but regulated under the Code de la santé publique (tobacco provisions) and subject to excise duties. France prohibits oral tobacco (snus) per EU directive but nasal tobacco is exempt.
ES Spain Legal
Rapé is legal in Spain. Not a controlled substance.
Spain implements the EU Tobacco Products Directive. Nasal snuff tobacco products are legal. Not listed in Spanish controlled substances schedules.
IT Italy Legal
Rapé is legal in Italy. Not a controlled substance.
Italy has a historical tradition of nasal snuff use. Rapé is regulated as a tobacco product under Italian implementation of the EU TPD. Not listed in controlled substance tables (DPR 309/1990).
US United States Legal
Rapé is legal in the United States. Tobacco products are not controlled substances.
Tobacco products are regulated by the FDA under the Family Smoking Prevention and Tobacco Control Act (2009). Smokeless tobacco products including snuff must carry health warnings. Nicotiana rustica is legal to cultivate and possess. Some rapé blends containing non-tobacco botanical additives may face additional regulatory scrutiny if health claims are made.
CA Canada Legal
Rapé is legal in Canada. Tobacco products are not controlled under the CDSA.
Smokeless tobacco products are regulated under the TVPA. Health Canada regulates tobacco product labelling and marketing. Nicotiana rustica is legal to grow. Import of tobacco products is subject to customs duties.
AU Australia Legal
Rapé is legal in Australia as a tobacco product, though import and sale of smokeless tobacco products face restrictions.
Australia has strict tobacco regulations. Smokeless tobacco products are legal to possess but their commercial sale is restricted or prohibited in several states and territories. Personal importation of small quantities for personal use is generally tolerated. Nicotiana rustica is not a controlled plant.
BR Brazil Legal
Rapé is legal in Brazil, its primary country of origin. It is produced by indigenous communities and widely available.
Brazil is the primary source of rapé worldwide. Indigenous peoples' right to produce and use traditional plant preparations is recognised under the Brazilian Constitution (Art. 231) and ANVISA does not classify rapé as a pharmaceutical product. Commercial rapé products may be subject to ANVISA regulation if marketed with health claims.
PE Peru Legal
Rapé is legal in Peru. Traditional plant preparations used by indigenous communities are culturally protected.
Peru recognises the traditional use of plant preparations by indigenous communities. Mapacho tobacco is deeply integrated into Amazonian ceremonial practices alongside ayahuasca. Not listed as a controlled substance.
Community Experiences
Share a single experience — does not affect the OpenMind Score.
Comments
Please log in to comment
Log inEverything in OpenMind
Track your use, check combinations and find safer use tips – even offline.
No comments yet.